Gastroaortic fistula as an early complication of esophagectomy.

Gastroaortic fistula following esophagogastrectomy is an uncommon and invariably fatal complication without urgent surgical intervention. We report 1 such case and review the world literature identifying 22 previous cases. It characteristically presents 2 to 3 weeks after esophagogastrectomy with an initial herald bleed, followed by a latent period with a mean duration of 10 hours (range: 30 minutes to 3 days) and final exsanguination.

Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases.

Survival benefit from hepatic artery embolization (HAE) or hepatic arterial infusion chemotherapy (HAI) in patients with unresectable colorectal liver metastases has not previously been assessed in a randomized controlled trial. Sixty-one patients were randomized, 20 to receive no treatment, 22 to receive HAE, and 19 to receive HAI with 5-fluorouracil and degradable starch microspheres. Both treatments were acceptable to the patients in terms of low treatment morbidity rate.